Data Collection for Patients With Low Grade Ovarian Carcinoma
| Status: | Recruiting |
|---|---|
| Conditions: | Ovarian Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 8/23/2018 |
| Start Date: | May 2006 |
| End Date: | May 2034 |
| Contact: | Lisa Nathan |
| Phone: | 713-745-3837 |
The goal of this psychosocial research study is to collect information on patients with one
of the above-mentioned low-grade tumors. Researchers want to maintain these patients'
information in a research database to help learn and better understand these tumor types and
to help develop better treatments for them.
This is an investigational study. There will be no cost for participating in this research
study. Up to 2000 patients from MD Anderson will take part in this study.
of the above-mentioned low-grade tumors. Researchers want to maintain these patients'
information in a research database to help learn and better understand these tumor types and
to help develop better treatments for them.
This is an investigational study. There will be no cost for participating in this research
study. Up to 2000 patients from MD Anderson will take part in this study.
Low-grade tumors of female organs are considered rare. Because of this, doctors do not know
the best treatment for these kinds of tumors. Researchers want to learn more about patients'
experience with these types of cancer to help find ways to develop better therapies to treat
them.
If you agree to take part in this study, information about your type of cancer, the type of
treatment you had or are having, and details about your follow-up care will be entered into a
research database. These data will be collected from patients seen at MD Anderson since
January, 1950. This information will serve as a basis for research studies about patients
with low-grade ovarian tumors.
Your data will mostly come from your MD Anderson medical record. However, information may
also be requested from you, your local doctor, or an outside hospital. Information collected
from sources other than MD Anderson will be included in your MD Anderson medical record as
well as entered into this study's database.
Information may be directly collected from you, if there are additional questions not
provided in your medical records, if your information is not complete, or if your information
collected from other sources does not match what is in your MD Anderson medical record.
To help ensure confidentiality, the database will be password-protected with access strictly
limited to study staff.
This research database will be updated at least once a year to include information about your
current treatment and/or follow-up care. This information is usually collected from your MD
Anderson medical record, or it may be necessary to contact you directly. This information
will be collected indefinitely. If you wish to end your participation in this study, you may
request that your data remain in the database or that your information be deleted from the
database.
This is an investigational study. Up to 2000 patients from MD Anderson will take part in this
study.
the best treatment for these kinds of tumors. Researchers want to learn more about patients'
experience with these types of cancer to help find ways to develop better therapies to treat
them.
If you agree to take part in this study, information about your type of cancer, the type of
treatment you had or are having, and details about your follow-up care will be entered into a
research database. These data will be collected from patients seen at MD Anderson since
January, 1950. This information will serve as a basis for research studies about patients
with low-grade ovarian tumors.
Your data will mostly come from your MD Anderson medical record. However, information may
also be requested from you, your local doctor, or an outside hospital. Information collected
from sources other than MD Anderson will be included in your MD Anderson medical record as
well as entered into this study's database.
Information may be directly collected from you, if there are additional questions not
provided in your medical records, if your information is not complete, or if your information
collected from other sources does not match what is in your MD Anderson medical record.
To help ensure confidentiality, the database will be password-protected with access strictly
limited to study staff.
This research database will be updated at least once a year to include information about your
current treatment and/or follow-up care. This information is usually collected from your MD
Anderson medical record, or it may be necessary to contact you directly. This information
will be collected indefinitely. If you wish to end your participation in this study, you may
request that your data remain in the database or that your information be deleted from the
database.
This is an investigational study. Up to 2000 patients from MD Anderson will take part in this
study.
Inclusion Criteria:
1) All patients seen at M.D. Anderson Cancer Center with the following tumor types or
diagnosis are eligible for inclusion in this database. This includes patients whose disease
progressed to a higher-grade carcinoma since the time of original diagnosis: Ovarian tumor
of low malignant potential, Low-grade serous carcinoma of the ovary, Primary peritoneal
tumor of low malignant potential, Low-grade serous carcinoma of the peritoneum,
Psammocarcinoma
Exclusion Criteria:
1) None
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
Principal Investigator: David Gershenson, MD
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
